Systematic Review: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
6 May, 2022 | 10:47h | UTCSummary: Cannabis and cannabinoids for people with multiple sclerosis – Cochrane Library
Commentary on Twitter
?A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms.
? Does it work? Are there harms?
? Cochrane systematic review looks at 25 RCTs ➡️ https://t.co/HCt6Cx3suo#MedicalMarijuana #MultipleSclerosis pic.twitter.com/wjDTXXEciM— The Cochrane Library (@CochraneLibrary) May 5, 2022